Literature DB >> 8099920

Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.

K Sugino1, T Mimura, K Toshima, H Iwabuchi, Y Kitamura, M Kawano, O Ozaki, K Ito.   

Abstract

Eight-year follow-up evaluation and analysis of factors related to postoperative thyroid dysfunction were made in 216 patients with Graves' disease treated by subtotal thyroidectomy. The postoperative status of thyroid function were as follows according to hypersensitive TSH level: 65 patients (30.1%) were euthyroid, 25 (11.5%) had overt hyperthyroidism requiring treatment, 14 (6.5%) had subclinical hyperthyroidism with normal thyroid hormone and suppressed TSH, 21 (9.8%) were overt hypothyroid requiring thyroid hormone replacement and 91 (41.1%) had latent hypothyroidism without hormone replacement. In order to know factors related to postoperative thyroid function, age, sex, preoperative levels of TSH receptor antibody (TRAb), thyroid antibody titers, degree of lymphocyte infiltration, duration of medical treatment, weight of the resected thyroid tissue and weight of the remnant thyroid tissue were determined. No factor except thyroid remnant and antimicrosomal antibody titer was related to postoperative thyroid function. The weight of remnant should be less than 6 g to avoid recurrent hyperthyroidism. As recurrence of hyperthyroidism was observed more than 5 yr after surgery, long follow-up is needed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099920     DOI: 10.1007/BF03344945

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  A statistical study of the clinical significance of lymphocytic and fibrocytic replacements in the hyperplastic thyroid gland.

Authors:  F B WHITESELL; B M BLACK
Journal:  J Clin Endocrinol Metab       Date:  1949-11       Impact factor: 5.958

2.  Retrospective reevaluation of the significance of thyroid microsomal antibody in the treatment of Graves' disease.

Authors:  N Hamada; K Ito; T Mimura; N Ishikawa; N Momotani; J Noh; Y Hosoda; H Morii
Journal:  Acta Endocrinol (Copenh)       Date:  1987-03

3.  Clinical evaluation of the response to surgical treatment of Graves' disease.

Authors:  Y Kasuga; A Sugenoya; S Kobayashi; G Kaneko; H Masuda; M Fujimori; F Iida
Journal:  Surg Gynecol Obstet       Date:  1990-04

4.  The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.

Authors:  N R Steel; J J Taylor; E T Young; J R Farndon; M Holcombe; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1987-01       Impact factor: 3.478

5.  The influence of remnant size, antithyroid antibodies, thyroid morphology, and lymphocyte infiltration on thyroid function after subtotal resection for hyperthyroidism.

Authors:  E Jörtsö; S Lennquist; B Lundström; K Norrby; S Smeds
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

6.  Prevention and management of hypothyroidism after thyroidectomy for thyrotoxicosis.

Authors:  W Michie; J S Beck; J E Pollet
Journal:  World J Surg       Date:  1978-05       Impact factor: 3.352

7.  Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation.

Authors:  A D Toft; W J Irvine; I Sinclair; D McIntosh; J Seth; E H Cameron
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

8.  Outcome of surgery for Graves' disease re-examined.

Authors:  E L Cusick; Z H Krukowski; N A Matheson
Journal:  Br J Surg       Date:  1987-09       Impact factor: 6.939

9.  Hypothyroidism after thyroidectomy for Graves's disease: a search for an explanation.

Authors:  M Van Welsum; T E Feltkamp; M J De Vries; R Doctor; J Van Zijl; G Hennemann
Journal:  Br Med J       Date:  1974-12-28

10.  An evaluation of several prognostic factors in the surgical treatment for thyrotoxicosis.

Authors:  M Makiuchi; M Miyakawa; A Sugenoya; R Furihata
Journal:  Surg Gynecol Obstet       Date:  1981-05
View more
  5 in total

1.  Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

2.  Subtotal thyroidectomy for benign multinodular goiter: a 6-month postoperative study of the remnant's function and sonographic aspect.

Authors:  Fawzy Bakiri; Menad Hassaïm; Mohamed-Sadreddine Bourouba
Journal:  World J Surg       Date:  2006-06       Impact factor: 3.352

3.  A prospective randomized comparison of bilateral subtotal thyroidectomy versus unilateral total and contralateral subtotal thyroidectomy for graves' disease.

Authors:  Shun-Yu Chi; Kun-Chou Hsei; Shyr-Ming Sheen-Chen; Fong-Fu Chou
Journal:  World J Surg       Date:  2005-01-18       Impact factor: 3.352

4.  Early recurrence of hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.

Authors:  K Sugino; T Mimura; O Ozaki; Y Kure; H Iwasaki; N Wada; A Matsumoto; K Ito
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

5.  Incidences of Hypothyroidism Associated With Surgical Procedures for Thyroid Disorders: A Nationwide Population-Based Study.

Authors:  Shin-Han Tsai; Shuo-Chen Chien; Phung-Anh Nguyen; Po-Han Chien; Hon-Ping Ma; Rahma Novita Asdary; Yao-Chin Wang; Ayesha Humayun; Chen-Ling Huang; Usman Iqbal; Wen-Shan Jian
Journal:  Front Pharmacol       Date:  2019-12-12       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.